We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Ultrasound Device Reduces the Number of Tests Required for Inpatients and Outpatients

By MedImaging International staff writers
Posted on 20 May 2015
The results of a study carried out by the European Association for the Study of the Liver (EASL; Geneva, Switzerland) into the use of a Pocket-sized Ultrasound Device (PUD) together with a physical examination, have been presented at the 2015 International Liver Congress, in Vienna (Austria).

The study evaluated the effectiveness of using a PUD, which offers performance comparable to standard ultrasonography, to reduce the need for further testing in both inpatient and outpatient settings, during a physical examination. The conditions tested under the study were biliary-duct dilation, gallstones, splenomegaly, ascites, pleural effusion, pericardial effusion, urinary stones, urinary retention, abdominal mass, and aortic aneurysm. The research included 1,962 patients, including 726 (37%) inpatients, 510 (26%) outpatients, and 726 (37%) patients recruited from physicians’ referrals.

The results showed that after some basic training, the PUD provided a simple and effective way to improve the accuracy of the clinician’s diagnosis, and reduce the number of tests needed by a patient. The PUD exam confirmed 66% of the clinical questions, in 90% of the cases. The overall frequency of further tests needed after use of the PUD was 37%. The rate of agreement between findings of the PUD and additional tests was 89%.

Related Links:

EASL 


X-ray Diagnostic System
FDX Visionary-A
Mobile X-Ray System
K4W
Ultrasound Needle Guidance System
SonoSite L25
Adjustable Mobile Barrier
M-458

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.